GSK: GSK's Blenrep combinations approved by MHRA to treat multiple myeloma
Approximately 6,500 new cases of the blood cancer are diagnosed in the UK each year
Read full article »
GSK is an England-based multinational biopharmaceutical company that develops and markets medicinal drugs and vaccines for the treatment of a variety of diseases.
Read more